Werkgroep Cardiologische centra Nederland

ADMIRE-ICD (Completed)

AdreView™ Myocardial Imaging for Risk Evaluation – A multicentre trial to guide ICD implantation in NYHA class II & III heart failure patients with 30%≤LVEF≤35%
Medicine
Jodium-123 meta-iodobenzylguanidine (MIBG)
Population
Heart failure
Phase
III
Starting year
2016
More information
ClinivalTrials.gov

Contact

dr. J. Schaap (Cardioloog)
Breda, Amphia Ziekenhuis